Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hour.

Acknowledgment of Support

This activity is supported by educational grants from GRAIL, Inc.

Altering the Course of Cancer in Primary Care: Early Detection for Better Long-Term Outcomes

Release Date: October 26, 2020
Expiration Date: October 26, 2021

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in the emerging field of early cancer detection by blood testing. In this educational program, these experts discuss the development of multicancer screening tests, the role of the primary care provider in early cancer screening, barriers to early cancer screening, the biomarkers that are being investigated, managing false positive results, and the role that early cancer screening plays in the cancer diagnosis pathway.

This educational activity is an archive of the live virtual symposium held on October 14, 2020.

Acknowledgement of Commercial Support

This activity is supported by educational grants from GRAIL, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward primary care physicians, nurse practitioners, physician assistants, and other health care professionals involved in screening patients for cancer. Other health care professionals interested in screening tests for cancer are invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Discuss the potential role of blood testing in detecting cancer in the primary care setting, including appropriate patient selection
  • Review biomarkers targeted by blood testing in cancer detection
  • Evaluate the sensitivity and specificity of blood tests for cancer detection
  • Use patient-centered approaches to effectively incorporate blood testing in screening and diagnosis of patients with cancer

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Thad Wilkins, MD, MBA, FAAFP
Thad Wilkins, MD, MBA, FAAFP
Professor of Family Medicine
Associate Chief Medical Officer, Utilization and Throughput
AU Health and the Medical College of Georgia at Augusta University
Augusta, GA

Disclosures: Thad Wilkins, MD, MBA, FAAFP, has no relevant financial relationships with commercial interests.


Tomasz M. Beer, MD
Tomasz M. Beer, MD
Professor of Medicine
Deputy Director, Knight Cancer Institute
Chief Medical Officer, CEDAR
Portland, OR

Disclosures: Grant/research Support: Alliance Foundation Trials, Astellas Pharma, Boehringer Ingelheim, Corcept Therapeutics, Endocyte, Freenome, GRAIL, Harpoon Therapeutics, Janssen Pharmaceuticals, Medivation, Sotio, Theraclone Sciences, Zenith; Consultant: Arvinas, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, GRAIL, Novartis, Pfizer, Sanofi; Shareholder: Arvinas, Salarius Pharmaceuticals.

Minetta C. Liu, MD
Minetta C. Liu, MD
Professor of Oncology, Mayo Clinic College of Medicine
Research Chair, Department of Oncology
Consultant, Department of Laboratory Medicine and Pathology
Medical Director, Office of Practice Specialty Collaborations and Contracts
Co-Leader, Genomics in Action Strategic Priority, Center for Individualized Medicine
Mayo Clinic
Rochester, MN

Disclosures: Other Support: Contracted Research, funds to Mayo: Eisai, Genentech, GRAIL, Menakinl, Merck, Novartis, Seattle Genetics, Tasako.

Lincoln D. Nadauld, MD, PhD
Lincoln D. Nadauld, MD, PhD
Vice President, Chief of Precision Health and Genomics
Intermountain Healthcare
Logan, UT

Disclosures: Lincoln D. Nadauld, MD, PhD, has no relevant financial relationships with commercial interests.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By